checkAd

EQS-News Achiko AG: 2021 Extraordinary Shareholders' Meeting of Achiko AG: shareholders adopt all proposals - Seite 2

Nachrichtenquelle: EQS Group AG
11.02.2021, 15:00  |  104   |   |   



"We are grateful to our shareholders and their support", Allen Wu, Chairman of Achiko said. "The resolutions today give the company the ability to continue with its transformation in delivering a range of relevant services in this pandemic".

About Achiko AG
We harness ground-breaking science with innovative technology to create solutions that provide a great user experience for patients, physicians and governing bodies alike, leading ultimately to the transformation of the healthcare industry.

The current development of our patent pending diagnostic testing for Covid-19 (Project Gumnuts) provides an easy and effective way that enables people to obtain the information they need and require. Complemented by our mobile check-in app (Teman Sehat), we empower users to manage their diagnostic experiences on their own terms, safeguard their privacy, share experiences, obtain passport verification and find community.

Achiko holds exclusive commercialisation rights to the technology underlying Project Gumnuts from Regenacellx.sl. It may be used to detect all types of Covid-19, but also many other pathogens. Achiko is looking forward to the completion of regulatory approval and getting the technology to market as quickly as possible, applying it in an array of test kits and other assay formats.

Headquartered in Zurich, we have offices in Hong Kong, Jakarta, Singapore and Seoul.
http://www.achiko.com

Media contacts:

ACHIKO AG
Investor Relations
E: ir@achiko.com

Switzerland
Marcus Balogh
Farner Consulting Ltd.
E: achiko@farner.ch
T: +41 44 266 67 67

Germany and Austria
Axel Mühlhaus / Dr Sönke Knop
edicto GmbH
E: achiko@edicto.de
T: +49 69 90 55 05-51

Disclaimer
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Seite 2 von 3
Achiko Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de




Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

EQS-News Achiko AG: 2021 Extraordinary Shareholders' Meeting of Achiko AG: shareholders adopt all proposals - Seite 2 EQS Group-News: Achiko AG / Key word(s): AGMEGM Achiko AG: 2021 Extraordinary Shareholders' Meeting of Achiko AG: shareholders adopt all proposals 11.02.2021 / 15:00 2021 Extraordinary Shareholders' Meeting of Achiko AG: shareholders adopt all …

Community

Nachrichten des Autors

Titel
Titel
Titel
Titel